Lee Edgar 4
4 · Sorrento Therapeutics, Inc. · Filed Dec 11, 2019
Insider Transaction Report
Form 4
Lee Edgar
Director
Transactions
- Award
Common Stock
2019-12-09+75,000→ 75,000 totalExercise: $3.81Exp: 2029-12-09→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]1/12 of the original number of shares subject to this option shall vest and become exercisable on January 1, 2020 and 1/12 of the original number of shares subject to the option shall vest following each one month of service thereafter, subject to the Reporting Person's continued service on the Issuer's board of directors on each such date.